Introduction: Depression is frequently associated with dementia of different etiologies, such as dementia of Alzheimer, vascular dementia, mixed dementia and that associate with Parkinson disease. In these cases, the treatment of depression, based on pharmacological or non-pharmacological interventions can bring advantages not only for the patient but also for his caregiver. Objective: This
... [Show full abstract] article reviews the use of different antidepressants in this context, considering the efficacy, the effects on the cognition, the potential effect in triggering confusional states and effects of clinical associated comorbidities. Methods: Search of the literature in MEDLINE database from 1966 up to April 2005, using the key words depression, dementia, antidepressants. Results: Eight double-blind placebo-controlled trials with antidepressants in depression associated with dementia were retrieved. The prescription of anti-depressants based in evidences from the few randomized controlled trials available may include the reversible monoamina oxidase inhibitor moclobemide, some serotonin re-uptake inhibitors (citalopram and sertraline) or the tricyclic antidepressant clomipramine. Conclusions: In face of the limited data concerning the pharmacological treatment of depression associated with cognitive deficits, up to the present there is no antidepressant or group of antidepressants of choice in this particular type of depression. Thus, the choice of an antidepressant must be individualized for each patient, based on its efficacy, its effects on cognition, the potential for triggering confusional states and the presence of clinical associate comorbidities.